OTC · Medical - Devices

Medacta Group S.A. (MEDGF) Stock

$83.91 +0.00% OTC: MEDGF Healthcare

Medacta Group SA is a global developer, manufacturer, and distributor of specialized orthopedic and neurosurgical medical devices. Its operations span Europe, North America, Asia-Pacific, and other international markets.

Valuation

MetricValue
Price$83.91
Market Cap$1.67B
P/E Ratio29.13
P/B Ratio6.18
P/S Ratio4.08
EPS (TTM)$2.88
52-Week High$83.91
52-Week Low$83.91
Dividend Yield1.69%

Financials & Margins

MetricValue
ROE21.69%
ROA10.42%
ROCE16.51%
Gross Margin67.08%
Operating Margin16.90%
Net Margin13.96%
Debt/Equity0.58
Current Ratio2.08

Annual Financials (USD)

Metric20212022202320242025
Revenue$363.0M$437.0M$511.0M$591.0M$688.0M
Operating Profit$59.0M$61.0M$74.0M$91.0M$116.0M
Net Profit$52.0M$46.0M$47.0M$73.0M$96.0M
EPS$2.58$2.31$2.37$3.65$4.81
Op Margin16.2%14.1%14.6%15.4%16.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$489.0M$584.0M$696.0M$792.0M$917.0M
Total Liabilities$263.0M$310.0M$366.0M$413.0M$461.0M
Cash$20.0M$32.0M$21.0M$32.0M$33.0M
Borrowings$133.0M$170.0M$202.0M$241.0M$262.0M

Latest News

Dow Jones Futures: Google, Tesla Fall On Earnings, Capex, But AI Stocks Climb Investor's Business Daily · Jul 23, 2026 Xinhua Silk Road: Mutton culture festival ignites summer food and tourism spree in E China county PR Newswire · Jul 23, 2026 Analysts Say This Robotics Stock Could Be One of 2026’s Biggest Industrial Winners 24/7 Wall St. · Jul 23, 2026 Regulatory capacity cleanup fuels Knight-Swift’s bullish outlook FreightWaves · Jul 23, 2026 Qualys (QLYS) Stock May Be 12% Overvalued As Cyber Threat Warnings Lift Interest Simply Wall St. · Jul 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$54.0M$74.0M$75.0M$107.0M$154.0M
Investing Cash Flow$-99.0M$-128.0M$-163.0M$-204.0M$-262.0M
Financing Cash Flow$-1.0M$-3.0M$-13.0M$-15.0M$-19.0M
Net Cash Flow$-28.0M$12.0M$-11.0M$11.0M$5.0M
Free Cash Flow$8.0M$10.0M$-7.0M$2.0M$30.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.92
EV / EBITDA15.85
FCF Yield1.06%
Quick Ratio0.80
Interest Coverage16.87
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held69.66%
Institutions Held15.24%
Institutions Float Held50.23%
Institutional HolderSharesReport Date
Artisan Partners Funds Inc.-Artisan International Fund273,4562026-03-31
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund87,3632026-04-30
Templeton Global Smaller Companies Fund66,4962026-05-31
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund58,1362026-03-31
iShares Trust-iShares Core MSCI EAFE ETF37,0942026-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
1858.HKBeijing Chunlizhengda Medical Instruments Co., Ltd. $9.53 +3.70% 11.21 $3.51B 4.96%
GNGBFGetinge AB (publ) $22.49 +0.00% 24.18 $5.72B 2.00%
GNNDYGN Store Nord A/S $41.99 -1.40% -35.71 $2.04B 0.00%
MDRSFMedartis Holding AG $115.00 +0.00% 130.60 $1.43B 0.00%
MDTMedtronic plc $87.54 +0.76% 21.27 $112.06B 3.49%

About Medacta Group S.A.

Medacta Group SA is a global developer, manufacturer, and distributor of specialized orthopedic and neurosurgical medical devices. Its operations span Europe, North America, Asia-Pacific, and other international markets. The firm provides advanced solutions, such as personalized kinematic models and cutting-edge 3D planning tools, designed to support a wide array of surgical procedures, including those for the hip, knee, shoulder, spine, and sports-related injuries. Established in 1958, Medacta maintains its corporate headquarters in Castel San Pietro, Switzerland.

Medacta Group S.A. is headquartered in CH.

Medacta Group S.A. (MEDGF) stock trades at $83.91 with a market capitalization of $1.67B. The stock is valued at a price-to-earnings (P/E) ratio of 29.13, price-to-book of 6.18, price-to-sales of 4.08. Over the past 52 weeks the stock has ranged between $83.91 and $83.91, and currently trades at its 52-week high. It pays a dividend yielding 1.69%.

On profitability, Medacta Group S.A. generates a return on equity (ROE) of 21.69% — well above the market average, a sign of a high-quality business, return on capital employed of 16.51%, an operating margin of 16.90%, a net profit margin of 13.96%.

Official website: www.medacta.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides